Global Comparator Drug Sourcing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Comparator Drug Sourcing Market Research Report 2024
Comparator drug sourcing is a sourcing approach whereby the comparator product is accepted within a single country and used in a clinical trial inside the same country. The product evades charges on import and export and regulations, which is considered to speed up the clinical trial supply chain and is cost-effective.
According to MRAResearch’s new survey, global Comparator Drug Sourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Comparator Drug Sourcing market research.
Key companies engaged in the Comparator Drug Sourcing industry include AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex and PHARMA’S ALMANAC, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Comparator Drug Sourcing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Comparator Drug Sourcing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Comparator Drug Sourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AmerisourceBergen Corporation
Avantor, Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.
Segment by Type
Local Sourcing
Central Sourcing
Market Sourcing
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Comparator Drug Sourcing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Comparator Drug Sourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Comparator Drug Sourcing market research.
Key companies engaged in the Comparator Drug Sourcing industry include AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex and PHARMA’S ALMANAC, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Comparator Drug Sourcing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Comparator Drug Sourcing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Comparator Drug Sourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AmerisourceBergen Corporation
Avantor, Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.
Segment by Type
Local Sourcing
Central Sourcing
Market Sourcing
Segment by Application
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Comparator Drug Sourcing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source